View by Specialty

Trending

Drinking more coffee and tea lowers the risk for developng multiple cardiometabolic disorders.
September 17, 2024
3 min read
Save

Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases

Practice Management News

SPONSORED CONTENT
Save
SPONSORED CONTENT
November 29, 2023
4 min read
Save

Q&A: Reexamining racial factors in clinical algorithms

Q&A: Reexamining racial factors in clinical algorithms

A reexamination of factoring race into clinical equations for patient care will require changes at each step of the algorithm life cycle, according to an expert.

SPONSORED CONTENT
November 29, 2023
3 min read
Save

Novel equations estimate long-term risk from cardiovascular-kidney-metabolic syndrome

Novel equations estimate long-term risk from cardiovascular-kidney-metabolic syndrome

PHILADELPHIA — A speaker unveiled the American Heart Association’s new PREVENT equations to evaluate 10- and 30-year absolute risk associated with cardiovascular-kidney-metabolic syndrome.

Trending

Drinking more coffee and tea lowers the risk for developng multiple cardiometabolic disorders.
September 17, 2024
3 min read
Save

Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases

SPONSORED CONTENT
November 13, 2023
2 min watch
Save

VIDEO: Unmet needs of patients with hyperphosphatemia

VIDEO: Unmet needs of patients with hyperphosphatemia

  Healio spoke with Daniel Coyne, MD, professor of medicine in the nephrology division at Washington University School of Medicine, about the challenges of managing hyperphosphatemia, new treatments and therapies, unmet needs in hyperphosphatemia management and more.

SPONSORED CONTENT
November 13, 2023
3 min watch
Save

VIDEO: Drugs in the pipeline for hyperphosphatemia management

VIDEO: Drugs in the pipeline for hyperphosphatemia management

  Healio spoke with Daniel Coyne, MD, professor of medicine in the nephrology division at Washington University School of Medicine, about the challenges of managing hyperphosphatemia, new treatments and therapies, unmet needs in hyperphosphatemia management and more.

SPONSORED CONTENT
November 13, 2023
2 min watch
Save

VIDEO: Biggest treatment challenges for patients with hyperphosphatemia

VIDEO: Biggest treatment challenges for patients with hyperphosphatemia

  Healio spoke with Daniel Coyne, MD, professor of medicine in the nephrology division at Washington University School of Medicine, about the challenges of managing hyperphosphatemia, new treatments and therapies, unmet needs in hyperphosphatemia management and more.

SPONSORED CONTENT
November 13, 2023
1 min watch
Save

VIDEO: Latest treatment advancements in hyperphosphatemia

VIDEO: Latest treatment advancements in hyperphosphatemia

  Healio spoke with Daniel Coyne, MD, professor of medicine in the nephrology division at Washington University School of Medicine, about the challenges of managing hyperphosphatemia, new treatments and therapies, unmet needs in hyperphosphatemia management and more.

SPONSORED CONTENT
November 13, 2023
3 min read
Save

Obinutuzumab improves odds of complete renal response, cuts flare risk in lupus nephritis

Obinutuzumab improves odds of complete renal response, cuts flare risk in lupus nephritis

SAN DIEGO — Obinutuzumab use increases the chances of achieving complete renal response and lowers the risk for kidney-related events and time to flare in lupus nephritis, according to data presented at ACR Convergence 2023.

SPONSORED CONTENT
November 13, 2023
4 min read
Save

How behavioral finance impacts physicians’ decision making

How behavioral finance impacts physicians’ decision making

Investing in the financial markets is a complex endeavor influenced not only by economic factors and market dynamics but also by human behavior.

SPONSORED CONTENT
November 11, 2023
4 min read
Save

Heterogeneity in germline susceptibility to renal cell carcinoma has genetic screening implications

Heterogeneity in germline susceptibility to renal cell carcinoma has genetic screening implications

NASHVILLE, Tenn. — An analysis of germline susceptibility to renal cell carcinoma revealed considerable heterogeneity, according to findings presented at International Kidney Cancer Symposium: North America.

SPONSORED CONTENT
November 08, 2023
2 min read
Save

Executive order directs HHS to monitor AI safety in health care

Executive order directs HHS to monitor AI safety in health care

President Joe Biden recently announced an executive order to establish standards for artificial intelligence safety, equity and security in health care and several other industries.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails